Public Company News

Daesang to Participate in "FiE 2025" in Paris, Strengthening Global Ingredient Competitiveness

- To be held over three days from the 2nd to the 4th in Paris, France, with 1,550 companies and more than 24,000 visitors expected. - Specialty ingredients including amino acids and microalgae to be showcased, along with tasting sessions featuring dishes made with the natural seasoning ingredien...

2025-12-01 21:00

YOULIFE ANNOUNCES CHANGES IN BOARD OF DIRECTORS AND MANAGEMENT

BEIJING, Dec. 1, 2025 /PRNewswire/ -- Youlife Group Inc. (Nasdaq: YOUL, "Youlife" or the "Company"), a leading blue-collar lifetime service provider in China, today announced changes in its board of directors (the "Board") and management. Changes in Board of Directors The Board has nominated and...

2025-12-01 20:00 206

Canadian Solar to Resume Direct Oversight of U.S. Manufacturing and Operations

KITCHENER, ON, Dec. 1, 2025 /PRNewswire/ -- Canadian Solar Inc.  ("Canadian Solar" or the "Company") (NASDAQ: CSIQ) today announced a strategic initiative to resume direct oversight of its U.S. operations and to continue reshoring manufacturing toNorth America. The ...

2025-12-01 20:00 213

MaxsMaking Inc. Addresses SEC Trading Suspension and Affirms Full Cooperation with Regulators

SHANGHAI, Dec. 1, 2025 /PRNewswire/ -- MaxsMaking Inc. (Nasdaq: MAMK) ("MaxsMaking" or the "Company"), a manufacturer of customized consumer goods with a focus on advanced technology and innovation, addresses the ten-day Order of Suspension of Trading in the securities of the Company entered by t...

2025-12-01 19:00 311

CN Energy Group. Inc. Announces Launch of PATHENBOT Robotics Solutions Platform and PATHENBOT's Official Website

LISHUI, China, Dec. 1, 2025 /PRNewswire/ -- CN Energy Group. Inc. ("CNEY" or the "Company") (NASDAQ: CNEY), a Nasdaq-listed company, today announced that its wholly owned subsidiary, PATHENBOT Group Inc. ("PATHENBOT"), has launched its robotics solutions platform and its official website (www.pat...

2025-12-01 18:55 390

XPENG Announces Vehicle Delivery Results for November 2025

* 36,728 vehicles delivered in November, up 19% YoY GUANGZHOU, China, Dec. 1, 2025 /PRNewswire/ -- XPeng Inc. ("XPENG" or the "Company," NYSE: XPEV and HKEX: 9868),a leading global AI mobility technology company, today announced its vehicle delivery results forNovember 2025. XPENG delivered 36,...

2025-12-01 17:28 444

Zeekr Group Announces November 2025 Delivery Update

HANGZHOU, China, Dec. 1, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new energy vehicle group, today announced its delivery results forNovember 2025. In November, Zeekr Group delivered a total of 63,90...

2025-12-01 16:00 369

BioDlink Showcases Europe-China CMC Collaboration Amid Developmental Breakthrough

* Recognized as Biologics CDMO of the Year, BioDlink shares insights into the world's first approved EGFR-targeted ADC for recurrent/metastatic nasopharyngeal carcinoma * The company enables seamless Europe–China tech transfer and faster biologics development through an integrated, end-to-end...

2025-11-28 21:00 623

Imugene and JW Therapeutics Announce a Collaboration to Advance onCARlytics and Carteyva® Combination in Solid Tumours

* Imugene and JW Therapeutics (Shanghai) Co., LTD have entered a strategic collaboration to evaluate a novel combination therapy using Imugene's onCARlytics (CF33-CD19) oncolytic virus and JW's CD19 CAR-T cell therapy, Carteyva®, in refractory solid tumors. * The collaboration includes precli...

2025-11-28 13:00 863

VIVOTEK Wins Two TCSA Awards for Sustainable Impact in Security

Enhancing Governance and Carbon Reduction with AI-Driven Security TAIPEI, Nov. 27, 2025 /PRNewswire/ -- VIVOTEK (3454-TW), the leading global security solution provider, continues to deepen its commitment to sustainability and has been recognized with two distinctions at the 18th Taiwan Corporat...

2025-11-27 23:30 1137

GC Genome Publishes Blood-Based Colorectal Cancer Screening Study in the American Journal of Gastroenterology

YONGIN, South Korea, Nov. 27, 2025 /PRNewswire/ -- GC Genome, a leading clinical genomics and liquid biopsy company, announced that its collaborative study with Professor Byeon, Jeong-Sik's team at Asan Medical Center has been published inThe American Journal of Gastroenterology(AJG). GC Genom...

2025-11-27 13:00 683

SK Biopharmaceuticals Expands Radiopharmaceutical Therapy Portfolio with Second In-licensed Candidate from Wisconsin Alumni Research Foundation

New addition strengthens SK Biopharmaceuticals' radiopharmaceutical therapy portfolio and reinforces its R&D capabilities through global partnerships and value chain integration SEOUL, South Korea, Nov. 26, 2025 /PRNewswire/ -- SK Biopharmaceuticals, CO., Ltd., a biotech company specializing in ...

2025-11-27 10:39 812

Scienjoy Holding Corporation Reports Nine Months ended September 30, 2025 Unaudited Financial Results

Revenue decrease by 5.3% but Income from Operations up 30.9% Year Over Year BEIJING, Nov. 26, 2025 /PRNewswire/ -- Scienjoy Holding Corporation ("Scienjoy", the "Company", or "we") (NASDAQ: SJ), an interactive entertainment leader in the Chinese market, today announced its unaudited financial res...

2025-11-27 05:30 1738

Nota AI Signs Technology Collaboration Agreement with Samsung Electronics for Exynos AI Optimization

"Driving the Popularization of On-Device Generative AI" -    Nota AI's optimization technology integrated into Samsung Electronics' Exynos AI Studio, enhancing efficiency in on-device AI model development SEOUL, South Korea, Nov. 26, 2025 /PRNewswire/ -- Nota AI, a company specializing in AI mo...

2025-11-26 21:00 703

Nagarro expands in Japan with the acquisition of Inaho Digital Solutions

TOKYO, Nov. 26, 2025 /PRNewswire/ -- Nagarro, a global leader in digital engineering, announced today the acquisition of Inaho Digital Solutions (IDS), a boutique IT service provider specialized in modernizing legacy applications and in SAP S/4HANA transformations inJapan and for Japanese clients...

2025-11-26 19:06 1540

Fibocom Brings Next-Generation Wireless and AI Solutions to MWC Doha 2025

DOHA, Qatar, Nov. 26, 2025 /PRNewswire/ -- Fibocom (300638.SZ | 0638.HK), a global leader in wireless communication modules and edge AI solutions, is showcasing its latest innovations atMobile World Congress (MWC) Doha 2025 at the Doha Exhibition and Convention Center. Fibocom presents a comprehe...

2025-11-26 18:17 639

Four Seasons Education to Report First Half of Fiscal Year 2026 Unaudited Financial Results

SHANGHAI, Nov. 26, 2025 /PRNewswire/ -- Four Seasons Education (Cayman) Inc. ("Four Seasons Education" or the "Company") (NYSE: FEDU), a tourism and education-related service provider inChina, today announced that it will report its unaudited financial results for the first half of fiscal year 20...

2025-11-26 17:45 593

Cheetah Mobile Announces Third Quarter 2025 Unaudited Consolidated Financial Results

BEIJING, Nov. 26, 2025 /PRNewswire/ -- Cheetah Mobile Inc. (NYSE: CMCM) ("Cheetah Mobile" or the "Company"), a China-based IT company, today announced its unaudited consolidated financial results for the quarter endedSeptember 30, 2025. Management Commentary Mr. Sheng Fu, Cheetah Mobile's Chair...

2025-11-26 17:00 1812

AEWIN Introduces BIS-5132 Series -- 2U High-Performance General-Purpose Servers Powered by Intel Xeon 6 Processors

TAIPEI, Nov. 26, 2025 /PRNewswire/ -- AEWIN unveils the BIS-5132-2U, a versatile 2U general-purpose server powered by Intel's latest Xeon 6 processors built on Intel 3 process technology. Featuring a single Intel Xeon 6700/6500-series CPU, the BIS-5132 delivers exceptional compute density with up...

2025-11-26 15:01 726

Celltrion announces publication of post-hoc analysis of LIBERTY-CD study of ZYMFENTRA®  (infliximab-dyyb), indicating consistent efficacy across disease location, including the terminal ileum in Clinical Gastroenterology and Hepatology journal

* Findings from the post-hoc analysis of LIBERTY-CD study indicates efficacy of ZYMFENTRA® (subcutaneous infliximab) regardless of disease location, consistent across ileum-dominant and colon-dominant Crohn's disease (CD) * Findings support the therapeutic potential of ZYMFENTRA in addressing ...

2025-11-26 14:48 1324
12345 ... 779